Monday, May 11, 2009

Nearly one-third of cancer research published in high-impact journals disclosed a conflict of interest

Not surprising in the least. But something to be aware of. Most cancer diagnoses, not only come with a huge emotional shock, but with pressure to hurry and "do" something. The best thing might be to stop and take a deep breath, then do some real research, including into alternative remedies. What the doctor recommends may or may not also contain motivations that not include the best interests of the actual patient--you.

--------------------------------------------------------------------------------------------
From Newswise, the journalists'-only site:

Newswise — Nearly one-third of cancer research published in high-impact journals disclosed a conflict of interest, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center.

The most frequent type of conflict was industry funding of the study, which was seen in 17 percent of papers. Twelve percent of papers had a study author who was an industry employee. Randomized trials with reported conflicts of interest were more likely to have positive findings.

“Given the frequency we observed for conflicts of interest and the fact that conflicts were associated with study outcomes, I would suggest that merely disclosing conflicts is probably not enough. It’s becoming increasingly clear that we need to look more at how we can disentangle cancer research from industry ties,” says study author Reshma Jagsi, M.D., D.Phil., assistant professor of radiation oncology at the U-M Medical School.

The researchers looked at 1,534 cancer research studies published in prominent journals. Results of this current study appear online in the journal Cancer.

“A serious concern is individuals with conflicts of interest will either consciously or unconsciously be biased in their analyses. As researchers, we have an obligation to treat the data objectively and in an unbiased fashion. There may be some relationships that compromise a researcher’s ability to do that,” Jagsi says.

For example, she says, researchers might design industry-funded studies in a way that’s more likely to produce favorable results. They might also be more likely to publish positive outcomes than negative outcomes.